Anxiety: An Early Indicator of Alzheimer ’s Disease?
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of Alzheimer ’s disease in older (Source: BWH for Journalists)
Source: BWH for Journalists - January 12, 2018 Category: Research Source Type: news
Slow-Release Pill Developed to Deliver HIV Therapeutics
Using an ingestible “mini pill box,” researchers investigate a once weekly pill to combat HIV (Source: BWH for Journalists)
Source: BWH for Journalists - January 9, 2018 Category: Research Source Type: news
Topiramate in Early Pregnancy Increases Risk of Oral Clefts
Study finds that taking a higher dose of the drug in the first trimester increases risk of cleft lip or cleft palate more than taking a lower dose. (Source: BWH for Journalists)
Source: BWH for Journalists - December 27, 2017 Category: Research Source Type: news
Testing the Accuracy of FDA-Approved and Lab-Developed Cancer Genetics Tests
Study finds that both laboratory-developed tests and FDA-approved companion diagnostics performed equally well (Source: BWH for Journalists)
Source: BWH for Journalists - December 14, 2017 Category: Research Source Type: news
Up to $70 Million To Be Awarded to Advance Alzheimer ’s Disease Clinical Trials
Reisa Sperling, MD, and collaborators will build the Alzheimer ’s Clinical Trials Consortium (ACTC) to accelerate, expand Alzheimer’s disease therapeutic research. (Source: BWH for Journalists)
Source: BWH for Journalists - December 11, 2017 Category: Research Source Type: news
Dana-Farber/Brigham and Women & #39;s Cancer Center launches new program to target aggressive thyroid cancers
New program specializes in targeted treatments for patients with advanced and aggressive thyroid cancers. (Source: BWH for Journalists)
Source: BWH for Journalists - December 7, 2017 Category: Research Source Type: news
Removing Cancer Cell Debris Improves Conventional Cancer Treatments
Researchers from Brigham and Women ’s Hospital and colleagues show that leftover debris can stimulate inflammation and tumor growth, but that molecules called resolvins can block that unwanted inflammatory response. (Source: BWH for Journalists)
Source: BWH for Journalists - November 30, 2017 Category: Research Source Type: news
Weight loss and risk of death: Rheumatoid arthritis findings may have wider implications
Findings from previous studies regarding lower weight being associated with higher mortality may not be directly related to RA and instead reflect a more generalized phenomenon. (Source: BWH for Journalists)
Source: BWH for Journalists - November 30, 2017 Category: Research Source Type: news
Performance-Enhancing Drugs Sold Via the Internet Are Inaccurately Labeled
Selective androgen receptor modulators (SARMs) found to contain substances not listed on the label or amounts of drug different from label. (Source: BWH for Journalists)
Source: BWH for Journalists - November 28, 2017 Category: Research Source Type: news
Social Networks and Survival: Social Ties Could Help with Cancer Management
women with stronger social networks had better survival after colorectal cancer diagnosis (Source: BWH for Journalists)
Source: BWH for Journalists - November 21, 2017 Category: Research Source Type: news
Investigating Patterns of Degeneration in Alzheimer ’s Disease
Researchers from Brigham and Women ’s Hospital have found that factors encoded in the DNA of brain cells contribute to the patterns of degeneration, or vulnerability, in AD. (Source: BWH for Journalists)
Source: BWH for Journalists - November 16, 2017 Category: Research Source Type: news
A Delicate Crossing: Controller Developed to Open the Blood-Brain Barrier with Precision
Controller offers finer degree of control and safety when opening the blood-brain barrier in preclinical models (Source: BWH for Journalists)
Source: BWH for Journalists - November 13, 2017 Category: Research Source Type: news
PCSK9 Inhibitor Improves Outcomes for Patients with Peripheral Artery Disease
LDL-cholesterol-lowering drug evolocumab reduced risk of major cardiovascular events and major adverse limb events among peripheral artery disease sub-population from the FOURIER trial. (Source: BWH for Journalists)
Source: BWH for Journalists - November 13, 2017 Category: Research Source Type: news
Response After Single Treatment with Canakinumab Predicts Which Patients Will Benefit Most
New analysis from CANTOS finds that measuring hsCRP levels after one dose of canakinumab can identify individuals likely to see greatest improvements from continued treatment. (Source: BWH for Journalists)
Source: BWH for Journalists - November 13, 2017 Category: Research Source Type: news
New Blood Test Developed to Diagnose Ovarian Cancer
Non-invasive diagnostic tool being developed to measure circulating microRNAs to predict ovarian cancer with specificity. (Source: BWH for Journalists)
Source: BWH for Journalists - October 31, 2017 Category: Research Source Type: news
